Professors urge Federal Circuit to revive Cleveland Clinic biotech…

A group of six patent law professors last week urged a federal appeals court to recognize the validity of diagnostic testing patents owned by the Cleveland Clinic, saying lower courts are improperly canceling biotech patents based on a misunderstanding of what constitutes eligible subject matter.